Emerging research is reshaping how we approach chronic and recurrent GI disease in dogs and cats. This webinar is designed for veterinary professionals seeking practical, evidence-based strategies to restore gut health by addressing Peptacetobacter hiranonis and the feline-specific P. felis—key commensals essential for bile acid metabolism, microbiome stability, and pathogen control. Learn how common antibiotic exposures can create long-lasting dysbiosis, and review compelling data from placebo-controlled field trials showing how targeted live Peptacetobacter restoration improved microbial and metabolic balance, clinical outcomes, and durability of response, with clear guidance for integrating this approach into everyday clinical practice.

Learning Objectives

Participants will learn how to:

• Understand the clinical importance of Peptacetobacter hiranonis and P. felis in canine and feline GI health, including their role in bile acid metabolism and microbiome stability.
• Recognize how antibiotic exposure disrupts Peptacetobacter populations and contributes to bile acid dysmetabolism, dysbiosis, and chronic or recurrent GI disease.
• Identify microbial, metabolic, and clinical patterns associated with Peptacetobacter depletion in dogs and cats.
• Review evidence from controlled clinical studies evaluating targeted Peptacetobacter restoration and its impact on microbial balance and clinical outcomes.
• Apply evidence-based strategies to integrate Peptacetobacter-based probiotics into everyday GI case management, including post-antibiotic recovery and chronic GI support.